Skip to main content
Daily Report

Daily Anesthesiology Research Analysis

08/07/2026
3 papers selected
36 analyzed

Analyzed 36 papers and selected 3 impactful papers.

Summary

The most impactful studies addressed the reliability of perioperative evidence, prevention of post-induction hypotension, and anesthesia selection for endovascular treatment of medium or distal vessel occlusion stroke. Together, they emphasize that apparently established perioperative practices may be statistically fragile, that routine preoperative crystalloid loading may not prevent hypotension, and that local anesthesia may offer advantages over conscious sedation in selected stroke procedures.

Research Themes

  • Reliability and fragility of perioperative evidence
  • Prevention of post-induction hypotension
  • Anesthesia modality for endovascular stroke treatment

Selected Articles

1. Effect of Pre-operative Intravenous Crystalloid Bolus on Post-Induction Blood Pressure - a randomized blinded intervention trial.

82.5Level IRCT
Anesthesiology · 2026PMID: 42565471

In this two-center randomized blinded trial of 504 high-risk adults undergoing major non-cardiac surgery, a crystalloid bolus administered within approximately 60 minutes before induction did not reduce the time-weighted average of mean arterial pressure below 65 mmHg during the first 20 minutes after induction. The negative result challenges routine preoperative fluid loading as a strategy to prevent post-induction hypotension.

Impact: This is a clinically relevant negative randomized trial addressing a common but insufficiently supported perioperative intervention. It suggests that fluid administration should be individualized rather than routinely used to prevent post-induction hypotension.

Clinical Implications: Routine pre-induction crystalloid boluses should not be assumed to prevent post-induction hypotension in cardiovascular-risk patients undergoing major non-cardiac surgery. Clinicians should prioritize individualized hemodynamic assessment, appropriate vasopressor readiness, and targeted treatment of hypotension.

Key Findings

  • The analysis included 504 patients: 247 received preoperative crystalloid and 257 received standard care.
  • The time-weighted average of mean arterial pressure below 65 mmHg did not differ significantly between groups: 0.0 mmHg versus 0.0 mmHg, P=0.368.
  • A crystalloid bolus within 60 minutes before induction did not prevent post-induction hypotension.

Methodological Strengths

  • Prospective randomized blinded intervention design conducted at two academic centers.
  • A clinically relevant blood-pressure exposure measure was used rather than relying only on a binary hypotension outcome.

Limitations

  • The intervention was single-blind rather than fully double-blind.
  • The findings apply primarily to patients aged 45 years or older with cardiovascular risk factors undergoing major non-cardiac surgery and may not generalize to other populations or fluid strategies.

Future Directions: Future trials should compare individualized fluid and vasopressor strategies, incorporate baseline volume-responsiveness assessment, and evaluate patient-centered outcomes such as organ injury, postoperative complications, and length of stay.

BACKGROUND: Post-induction hypotension in major non-cardiac surgery is common and a modifiable risk factor for adverse outcomes. There is an ongoing debate whether pre-operative crystalloid fluid administration can reduce the incidence or severity of post-induction hypotension. This study aims to assess whether a pre-operative intravenous crystalloid bolus reduces post-induction hypotension in high-risk patients under general anesthesia. METHODS: This was a prospective, randomized, single-blind clinical trial conducted at two centers in Austria.

2. Fragility Index of Randomized Clinical Trials in Perioperative Anesthesia: A Methodological Survey of Guideline-Supporting Evidence.

80Level IISystematic Review
Anesthesiology · 2026PMID: 42565467

This methodological survey evaluated 161 superiority RCTs supporting perioperative anesthesia guidelines and found a median Fragility Index of 4, meaning that changing outcomes in only a few participants could eliminate statistical significance. The findings indicate that guideline recommendations may depend on numerically unstable results and that fragility should complement, rather than replace, conventional risk-of-bias and certainty assessments.

Impact: The study directly interrogates the numerical stability of evidence used to support clinical guidelines rather than relying solely on nominal P values. It provides a practical framework for interpreting perioperative RCTs and identifying recommendations that require confirmatory research.

Clinical Implications: Clinicians and guideline developers should interpret statistically significant perioperative RCT findings in light of the number of outcome events, Fragility Index, confidence intervals, risk of bias, and evidence certainty. Recommendations based on highly fragile trials may warrant cautious implementation and confirmatory multicenter trials.

Key Findings

  • Of 1,868 identified RCTs, 639 met eligibility criteria and 161 superiority trials were included in the primary analysis.
  • The median sample size was 120 participants and the median Fragility Index was 4, with an interquartile range of 2-8.
  • Pediatric trials had the lowest median Fragility Index of 1, whereas cardiovascular trials had the highest median of 6.
  • Single-center trials were associated with lower Fragility Index values than multicenter trials.

Methodological Strengths

  • Systematic identification of RCTs cited in North American and European clinical practice guidelines.
  • Evaluation included Fragility Index, Reverse Fragility Index, Fragility Quotient, and exploratory regression of trial characteristics.

Limitations

  • The primary analysis was restricted to superiority trials with binary outcomes, limiting applicability to other trial designs and continuous outcomes.
  • Fragility metrics do not account for all dimensions of methodological quality, clinical importance, or confidence-interval precision.

Future Directions: Future research should integrate fragility metrics with risk-of-bias tools, absolute treatment effects, confidence intervals, Bayesian analyses, and replication data. Guideline panels could prospectively report the numerical stability of pivotal evidence.

BACKGROUND: The Fragility Index (FI) quantifies how small changes in trial outcomes can alter statistical significance, providing a measure of the numerical stability of randomized controlled trial (RCT) results. Despite its growing use, fragility has not been systematically examined in the perioperative evidence supporting anesthesiology guidelines. This study evaluated the FI, Reverse Fragility Index (rFI), and Fragility Quotient (FQ) of RCTs cited in North American and European perioperative clinical practice guidelines and explored trial characteristics associated with fragility. METHODS: We conducted a methodological survey of RCTs referenced in clinical practice guidelines (CPGs) published between 2012 and 2022.

3. Effect of anaesthesia modality on outcome in medium or distal vessel occlusion stroke: a post-hoc analysis of the DISTAL trial.

71.5Level IICohort
European stroke journal · 2026PMID: 42566703

Among 491 patients in a post-hoc analysis of the randomized DISTAL trial, endovascular treatment under conscious sedation was associated with worse 90-day functional outcome than best medical treatment alone. Compared with conscious sedation, local anesthesia was associated with higher odds of better functional outcome and lower mortality, while general anesthesia was associated with more symptomatic intracranial hemorrhage than best medical treatment alone.

Impact: The study addresses an important modifiable procedural factor in a controversial stroke-treatment population. Although observational confounding remains possible, the findings support prospective evaluation of anesthesia strategy and suggest that avoiding routine conscious sedation may be clinically relevant.

Clinical Implications: For selected patients undergoing endovascular treatment for medium or distal vessel occlusion, local anesthesia may be considered when feasible, particularly when conscious sedation could compromise procedural or neurologic management. Anesthesia choice should remain individualized, and these post-hoc findings should not be interpreted as definitive causal evidence.

Key Findings

  • The analysis included 491 patients: 224 received endovascular treatment plus best medical treatment and 267 received best medical treatment alone.
  • Conscious sedation during endovascular treatment was associated with worse 90-day modified Rankin Scale outcome than best medical treatment alone: adjusted odds ratio 0.51, 95% CI 0.29-0.90.
  • Local anesthesia compared with conscious sedation was associated with better functional outcome: adjusted odds ratio 2.11, 95% CI 1.09-4.12, and lower mortality: adjusted odds ratio 0.28, 95% CI 0.08-0.95.
  • General anesthesia was associated with more symptomatic intracranial hemorrhage than best medical treatment alone: 8.3% versus 2.6%.

Methodological Strengths

  • The analysis was based on a large contemporary randomized trial conducted across 55 centers.
  • It compared multiple anesthesia modalities with both head-to-head comparisons and the best-medical-treatment group.

Limitations

  • Anesthesia modality was selected at investigators' discretion and was not randomized, leaving substantial risk of confounding by indication.
  • This was a post-hoc analysis, and subgroup sample sizes were relatively small, particularly for local anesthesia and conscious sedation.

Future Directions: Prospective trials should randomize anesthesia modality or use robust causal-inference methods, while standardizing blood-pressure targets, ventilation, procedural duration, and rescue conversion to general anesthesia. Studies should also examine patient selection and center-level expertise.

INTRODUCTION: Of the 3 published trials, only 1 showed possible efficacy of endovascular treatment (EVT) compared to best medical treatment (BMT) alone for medium or distal vessel occlusions (MDVO), whereas the others were neutral. Procedural conditions may affect the outcome. PATIENTS AND METHODS: This is a post-hoc analysis of the randomised, controlled DISTAL trial, conducted in 55 centers between 12/2021 and 7/2024. Patients with isolated MDVO within 24 hours of last seen well randomised to EVT plus BMT were treated under general anaesthesia (GA), conscious sedation (CS) or local anaesthesia (LA) at investigators' discretion. Endovascular treatment under different anaesthesia modalities was compared head-to-head, and to BMT alone.